SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-025921
Filing Date
2021-02-02
Accepted
2021-02-02 16:39:55
Documents
16
Period of Report
2021-01-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d120548d8k.htm   iXBRL 8-K 32361
2 EX-1.1 d120548dex11.htm EX-1.1 137758
3 EX-5.1 d120548dex51.htm EX-5.1 11942
7 GRAPHIC g120548g0202233323180.jpg GRAPHIC 1785
8 GRAPHIC g120548g0202234514583.jpg GRAPHIC 2267
  Complete submission text file 0001193125-21-025921.txt   354225

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA evlo-20210128.xsd EX-101.SCH 3056
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE evlo-20210128_lab.xml EX-101.LAB 18121
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE evlo-20210128_pre.xml EX-101.PRE 11395
9 EXTRACTED XBRL INSTANCE DOCUMENT d120548d8k_htm.xml XML 3351
Mailing Address 620 MEMORIAL DRIVE SUITE 200 WEST CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 200 WEST CAMBRIDGE MA 02139 617 870 8281
Evelo Biosciences, Inc. (Filer) CIK: 0001694665 (see all company filings)

IRS No.: 465594527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38473 | Film No.: 21582019
SIC: 2834 Pharmaceutical Preparations